thiophenes has been researched along with Infarction, Middle Cerebral Artery in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, HA; Ergul, A; Fagan, SC; Fouda, AY; Hardigan, T; Ishrat, T; Kozak, A; Pillai, B | 1 |
| Ichijo, M; Ishibashi, S; Iwasawa, E; Li, F; Miki, K; Suzuki, M; Yokota, T | 1 |
| Ahmed, HA; Eldahshan, W; Ergul, A; Fagan, SC; Fouda, AY; Ishrat, T; Pillai, B; Sayed, MA; Waller, JL | 1 |
| Bolbrinker, J; Douros, A; Ebinger, M; Kreutz, R; Schlemm, L | 1 |
| Fukae, J; Higashi, T; Inoue, T; Iwaasa, M; Kimura, S; Ogata, T; Okawa, M; Tsuboi, Y | 1 |
| Boato, F; Clausen, BH; Dahlöf, B; Denton, KM; Hallberg, A; Horiuchi, M; Iwai, M; Lambertsen, KL; Lucht, K; Müller, S; Namsolleck, P; Schwengel, K; Steckelings, UM; Thöne-Reineke, C; Unger, T; Valero-Esquitino, V; Widdop, RE | 1 |
| Brown, DA; Chang, FL; Curfman, ET; Kuo, PC; Paraiso, HC; Scofield, BA; Yen, JH; Yu, IC | 1 |
| Dhandapani, KM; Ergul, A; Fagan, SC; Fouda, AY; Pillai, B | 1 |
| Hasegawa, Y; Rolland, W; Sozen, T; Suzuki, H; Zhang, JH | 1 |
| Camaioni, E; Chen, Y; Chiarugi, A; Cozzi, A; Formentini, L; Gonzales, C; Liang, S; Moroni, F; Pellegrini-Giampietro, DE; Pellicciari, R; Wood, A; Zaleska, MM | 1 |
| Napoli, C | 1 |
| Chabrier, PE; Croci, N; Ding-Zhou, L; Marchand-Verrecchia, C; Margaill, I; Palmier, B; Plotkine, M | 1 |
| Pfefferkorn, T; Rosenberg, GA | 1 |
| Auguet, M; Chabrier, PE; Cornet, S; Demerlé-Pallardy, C; Marin, JG; Spinnewyn, B | 1 |
| Campbell, CA; Chapman, GA; Harrison, D; Moores, K; Stewart, BR; Strijbos, PJ | 1 |
| Ago, T; Fujishima, M; Ibayashi, S; Kitayama, J; Kitazono, T; Ooboshi, H; Takaba, H; Yao, H | 1 |
| Attucci, S; Cozzi, A; Meli, E; Moroni, F; Noe, C; Pellegrini-Giampietro, DE; Pellicciari, R; Picca, R; Sarichelou, I; Scheideler, MA | 1 |
1 trial(s) available for thiophenes and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial.
Topics: Amyloid beta-Peptides; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Hypoxia; Cells, Cultured; Cognitive Dysfunction; Disease Models, Animal; Double-Blind Method; Endothelial Cells; Epoetin Alfa; Hippocampus; Humans; Infarction, Middle Cerebral Artery; Locomotion; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sensory Gating; Sulfonamides; Tetrazoles; Thiophenes | 2018 |
16 other study(ies) available for thiophenes and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke.
Topics: Animals; Diabetes Mellitus, Experimental; Imidazoles; Infarction, Middle Cerebral Artery; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Stroke; Sulfonamides; Thiophenes | 2022 |
Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.
Topics: Animals; Blood-Brain Barrier; Cell Line; Cerebrovascular Circulation; Collateral Circulation; Disease Models, Animal; Endothelial Cells; Infarction, Middle Cerebral Artery; Macrophages; Male; Meninges; Mice, Inbred BALB C; Monocytes; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Oxadiazoles; Phosphorylation; Receptors, Lysosphingolipid; Recovery of Function; Signal Transduction; Sphingosine-1-Phosphate Receptors; Thiophenes; Tight Junction Proteins; Time Factors | 2018 |
Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.
Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Biological Availability; Blood Coagulation; Dabigatran; Drug Monitoring; Drug Substitution; Factor Xa Inhibitors; Female; Humans; Infarction, Middle Cerebral Artery; Intestinal Absorption; Morpholines; Predictive Value of Tests; Pyridines; Risk Factors; Rivaroxaban; Short Bowel Syndrome; Thiophenes; Treatment Outcome | 2014 |
Revascularization for acute ischemic stroke is safe for rivaroxaban users.
Topics: Aged, 80 and over; Brain Ischemia; Cerebral Revascularization; Factor Xa Inhibitors; Female; Humans; Infarction, Middle Cerebral Artery; Morpholines; Rivaroxaban; Stroke; Thiophenes; Thrombectomy; Tissue Plasminogen Activator | 2014 |
Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice.
Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Cell Survival; Cerebral Cortex; Drug Evaluation, Preclinical; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2016 |
3H-1,2-Dithiole-3-thione as a novel therapeutic agent for the treatment of ischemic stroke through Nrf2 defense pathway.
Topics: Animals; Antioxidants; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Mice; NF-E2-Related Factor 2; Reactive Oxygen Species; Signal Transduction; Stroke; Thiones; Thiophenes | 2017 |
Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury.
Topics: Animals; Infarction, Middle Cerebral Artery; Interleukin-10; Male; Neuroprotective Agents; Oxygen; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Reperfusion Injury; Sulfonamides; Thiophenes | 2017 |
Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Fingolimod Hydrochloride; Immunosuppressive Agents; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; MAP Kinase Signaling System; Nerve Degeneration; Neuroprotective Agents; Oxadiazoles; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Stroke; Thiophenes; Treatment Outcome | 2010 |
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.
Topics: Animals; Body Weight; Brain; Disease Models, Animal; Enzyme Inhibitors; Female; HeLa Cells; Humans; Infarction, Middle Cerebral Artery; Isoquinolines; Male; Motor Activity; Neuroprotective Agents; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stroke; Thiophenes; Tumor Cells, Cultured | 2012 |
MMP inhibition and the development of cerebrovascular atherosclerosis: The road ahead.
Topics: Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Enzyme Inhibitors; Extracellular Matrix; Female; Glycine; Hemodynamics; Humans; Hydroxamic Acids; Infarction, Middle Cerebral Artery; Intracranial Arteriosclerosis; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Phenylalanine; Thiophenes; Treatment Outcome | 2002 |
Neuroprotective effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an inhibitor of neuronal nitric-oxide synthase and an antioxidant, in model of
Topics: Animals; Antioxidants; Blood-Brain Barrier; Brain Edema; Brain Infarction; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Mice; Nervous System Diseases; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Peroxidase; Pyrazines; Thiophenes | 2003 |
Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Phenylalanine; Rats; Rats, Wistar; Recombinant Proteins; Reperfusion; Sucrose; Survival Rate; Thiophenes; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Water | 2003 |
BN 80933 inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures.
Topics: Animals; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; Dinoprost; Enzyme Inhibitors; F2-Isoprostanes; Hypoxia, Brain; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Neuroprotective Agents; Pyrazines; Rats; Rats, Wistar; Reperfusion Injury; Thiophenes | 2000 |
Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage.
Topics: Animals; Animals, Newborn; Brain; Cell Membrane; Cells, Cultured; Chemokine CX3CL1; Chemokines, CX3C; Chemotaxis; Culture Media, Conditioned; Disease Models, Animal; Encephalitis; Endothelium, Vascular; Glutamic Acid; Infarction, Middle Cerebral Artery; Interleukin-1; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Membrane Proteins; Microglia; Monocytes; Neurons; Phenylalanine; Protease Inhibitors; Rats; RNA, Messenger; Thiophenes; Transfection; Tumor Necrosis Factor-alpha | 2000 |
Inhibition of Na+/H+ exchanger reduces infarct volume of focal cerebral ischemia in rats.
Topics: Animals; Brain Ischemia; Calcium; Cell Death; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Inbred SHR; Sodium; Sodium-Hydrogen Exchangers; Thiophenes; Treatment Outcome | 2001 |
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death.
Topics: Animals; Brain Ischemia; Cell Death; Cell Hypoxia; Cells, Cultured; Cricetinae; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hippocampus; Infarction, Middle Cerebral Artery; Mice; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Thiophenes | 2002 |